Exchange Traded Concepts, LLC Alkermes Plc. Transaction History
Exchange Traded Concepts, LLC
- $4.74 Billion
- Q4 2024
A detailed history of Exchange Traded Concepts, LLC transactions in Alkermes Plc. stock. As of the latest transaction made, Exchange Traded Concepts, LLC holds 30,950 shares of ALKS stock, worth $931,595. This represents 0.02% of its overall portfolio holdings.
Number of Shares
30,950
Previous 30,053
2.98%
Holding current value
$931,595
Previous $841,000
5.83%
% of portfolio
0.02%
Previous 0.02%
Shares
13 transactions
Others Institutions Holding ALKS
# of Institutions
360Shares Held
181MCall Options Held
175KPut Options Held
96.6K-
Black Rock Inc. New York, NY29.1MShares$876 Million0.02% of portfolio
-
Vanguard Group Inc Valley Forge, PA19MShares$571 Million0.01% of portfolio
-
Price T Rowe Associates Inc Baltimore, MD13MShares$391 Million0.04% of portfolio
-
Wellington Management Group LLP Boston, MA12.7MShares$381 Million0.06% of portfolio
-
State Street Corp Boston, MA9.19MShares$276 Million0.01% of portfolio
About Alkermes plc.
- Ticker ALKS
- Exchange NASDAQ
- Sector Healthcare
- Industry Drug Manufacturers—Specialty & Generic
- Shares Outstandng 164,254,000
- Market Cap $4.94B
- Description
- Alkermes plc, a biopharmaceutical company, researches, develops, and commercializes pharmaceutical products to address unmet medical needs of patients in various therapeutic areas in the United States, Ireland, and internationally. Its marketed products include ARISTADA, an intramuscular injectable suspension for the treatment of schizophrenia; ...